(Q55473369)

12 July 2018

title

Influence of p53 mutations on prognosis of patients with glioblastoma. (English)

1 reference

12 July 2018

0 references

Shoji Shiraishi

1

1 reference

12 July 2018

Kenji Tada

2

1 reference

12 July 2018

Hideo Nakamura

3

1 reference

12 July 2018

Keishi Makino

4

1 reference

12 July 2018

Masato Kochi

5

1 reference

12 July 2018

Hideyuki Saya

6

1 reference

12 July 2018

Jun-ichi Kuratsu

7

1 reference

12 July 2018

Yukitaka Ushio

8

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 July 2002

1 reference

12 July 2018

published in

Cancer

1 reference

12 July 2018

volume

95

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

249-257

1 reference

12 July 2018

Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Genetic alterations associated with the evolution and progression of astrocytic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

A case history of glioma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Genetic sub-types of human malignant astrocytoma correlate with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

The challenge of p53 as prognostic and predictive factor in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

p53 protein accumulation and gene mutations in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

A simple p53 functional assay for screening cell lines, blood, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

p76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparative study of p53 gene and protein alterations in human astrocytic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10677

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10677

1 reference

12 July 2018

1 reference

12 July 2018